Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Gains from Investment Securities (2020 - 2025)

Orthopediatrics (KIDS) has disclosed Gains from Investment Securities for 6 consecutive years, with -$4.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 49.44% to -$4.8 million in Q4 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a 50.47% decrease, with the full-year FY2023 number at -$3.0 million, up 88.51% from a year prior.
  • Gains from Investment Securities was -$4.8 million for Q4 2025 at Orthopediatrics, down from $1.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.1 million in Q1 2021 to a low of -$23.0 million in Q3 2022.
  • A 5-year average of -$1.7 million and a median of -$413500.0 in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 53566.67% in 2024, then soared 569.45% in 2025.
  • Orthopediatrics' Gains from Investment Securities stood at -$5.5 million in 2021, then skyrocketed by 91.29% to -$480000.0 in 2022, then surged by 98.75% to -$6000.0 in 2023, then tumbled by 53566.67% to -$3.2 million in 2024, then tumbled by 49.44% to -$4.8 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Gains from Investment Securities are -$4.8 million (Q4 2025), $1.5 million (Q3 2025), and $1.6 million (Q2 2025).